Fertility Market in the US 2016-2020 – Increasing Fertility Issues Among Aging Population – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/xvm6t8/fertility_market)
has announced the addition of the “Fertility
Market in the US 2016-2020″ report to their offering.
The fertility services market in the US is expected to grow at a CAGR of
4.07% during the period 2016-2020.
Couples with fertility issues are unable to conceive even after regular
unprotected coitus (six months if the woman is over age 35). Female or
male infertility factors account for one-third of the cases, where a
couple is unable to conceive. In the rest of the cases, the cause is
either unknown or a combination of both male and female infertility
factors.
Diagnosing the cause of infertility can be difficult but people with
fertility issues have many treatment options depending on the underlying
problem.
According to the report, the fertility market in the US consists of
fertility drugs and assisted reproductive technology (ART) services
segments. Increasing fertility issues among the aging population, rising
disposable income, growing adoption of fertility services by homosexual
couples, and augmented support from the US federal government are some
of the major factors that will impel growth in this market during the
forecast period.
The market is divided into the following segments based on treatment
type:
- ART
- Infertility drugs
Companies Mentioned:
- Cellcura
- CooperSurgical
- Intramed
- Ferring Pharmaceuticals
- Merck
- Abbott Laboratories
- AbbVie
- Actavis
- Apricus Biosciences
- AstraZeneca
- Auxogyn
- Bristol-Myers Squibb
- Elelixis Diagnostics
- Eli Lilly
- EMD Serono
- IKS International
- In Vitro Care
- Invo Bioscience
- Irvine Scientific
- IVFtech Aps
- Life Global
- Medical Electronic Systems
- Meditex
- Novartis
- Ovascience
- Pantec Biosolutions
- Pfizer
- Sanofi
- Vivus
- Xytex Cryo International.
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Regulatory scenario in the US
PART 06: Market landscape
PART 07: Infertility: An overview
PART 08: Stages of fertility treatment
PART 09: Cost analysis of ART
PART 10: Market segmentation by type
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
For more information visit http://www.researchandmarkets.com/research/xvm6t8/fertility_market
Contacts
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women’s
Health
